Latest Breaking News On - Neuropace company profile - Page 1 : comparemela.com

Research Analysts Issue Forecasts for NeuroPace, Inc s FY2028 Earnings (NASDAQ:NPCE)

Research Analysts Issue Forecasts for NeuroPace, Inc s FY2028 Earnings (NASDAQ:NPCE)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesLeerink partnrsCantor fitzgeraldNeuropace company profileOrbimed advisors llcKent lake capitalMorgan stanleyWells fargo companyNeuropace incCitigroup incBarclays plcFree reportGet free reportLake capitalNeuropace daily

Insider Selling: NeuroPace, Inc (NASDAQ:NPCE) Major Shareholder Sells $219,973 80 in Stock

Insider Selling: NeuroPace, Inc (NASDAQ:NPCE) Major Shareholder Sells $219,973 80 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesLeerink partnrsOrbimed advisors llcNeuropace company profileMorgan stanleyBarclays plcWells fargo companyKent lake capitalSecurities exchange commissionNeuropace incCitigroup incCantor fitzgeraldGet free reportExchange commissionAdvisors llcLake capital

NeuroPace, Inc (NASDAQ:NPCE) Major Shareholder Orbimed Advisors Llc Sells 15,690 Shares of Stock

NeuroPace, Inc (NASDAQ:NPCE) Major Shareholder Orbimed Advisors Llc Sells 15,690 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesLeerink partnrsBarclays plcNeuropace company profileMorgan stanleyOrbimed advisors llcWells fargo companyCantor fitzgeraldCitigroup incNeuropace incKent lake capitalGet free reportAdvisors llcLake capitalWells fargoNeuropace daily

NeuroPace, Inc (NASDAQ:NPCE) Receives $15 67 Consensus Target Price from Analysts

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target […]

United statesMartha morrellLeerink partnrsGeode capital managementNeuropace company profileSecurities exchange commissionWells fargo companyCitigroup incBarclays plcOrbimed advisors llcRenaissance technologiesSusquehanna international groupNeuropace incCantor fitzgeraldGet free reportStreet capital

NeuroPace, Inc (NASDAQ:NPCE) Major Shareholder Sells $6,692,916 51 in Stock

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) major shareholder Orbimed Advisors Llc sold 461,899 shares of the stock in a transaction dated Thursday, April 11th. The shares were sold at an average price of $14.49, for a total value of $6,692,916.51. Following the completion of the sale, the insider now directly owns 3,542,068 shares of […]

United statesLeerink partnrsNeuropace company profileMorgan stanleyWells fargo companySecurities exchange commissionMillennium managementCantor fitzgeraldRenaissance technologiesOrbimed advisors llcNantahala capital managementNeuropace incGet free reportExchange commissionSpace trading downCapital management